Physician profile
Athanasios Garbis
NPI 1083399976
$1,522.59
in general payments reported to CMS, 2019-2025
12 companies · $799 in 2025
The $799 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.68 · 2024: $703 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,522.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $370.30 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Inari Medical, INC. | $347.80 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Averitas Pharma INC. | $161.61 | 2024 | Qutenza |
| Integra Lifesciences Corporation | $158.82 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $138.49 | 2024-2025 | |
| Linvatec Corporation | $113.57 | 2025 | Neospan, Biobrace 23mm |
| Pinnacle, INC | $93.99 | 2024-2025 | |
| Solventum Corporation | $46.49 | 2024 | Prevena, Activ.A.C., V.A.C.Instill |
| Abbvie INC. | $29.55 | 2025 | |
| Convatec INC. | $26.91 | 2025 | |
| Paragon 28, INC. | $20.68 | 2023 | Mtp |
| Bioventus LLC | $14.38 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Garbis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.